By Manufacturer Type

Prescription Originator (NDA/ANDA-Held) Market Analysis

Cross-industry research covering Prescription Originator (NDA/ANDA-Held) across 1 market reportspanning Pharmaceuticals.

1 Reports
1 Industries

Reports Covering Prescription Originator (NDA/ANDA-Held)

Medical Cold Gel Market to Reach USD 1.8 Billion by 2033 at 5.2% CAGR

Pharmaceuticals·Market: USD 1.21 Billion (2025)·CAGR: 5.2%

Diclofenac sodium gel 1% (originally NDA 021234) and branded lidocaine topical formulations fall in this tier. Prescription cold gel products carry higher WAC and face gross-to-net pressure from PBM rebate negotiations and commercial formulary tiering decisions.

15%

Market Share

5.6%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments